Maruti, Honda, Mahindra and others stops manufacturing due to Covid19 outbreak


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Maruti Honda Mahindra and others stops manufacturing due to Covid19 outbreak
All automakers stops production til 31st March

Maruti Suzuki India (MSI), Mahindra & Mahindra and Honda Cars, recentlyannounced suspension of manufacturing activities across plants in the wake of the coronavirus outbreak in the country.

 MSI stopped production at its Gurgaon and Manesar plants with immediate effect, while Honda Cars India Ltd (HCIL) to end manufacturing at its two plants in the country till 31 March.

Meanwhile Mahindra & Mahindra (M&M) announced to suspend production at its manufacturing plants in Maharashtra.

Automaker Fiat also suspends  production in the country till the end of this month.

From other automobile companies,Hero MotoCorp and Honda Motorcycle and Scooter India (HMSI) suspended production across their manufacturing plants.

HMSI said, "The company will shut production and office operations at its facilities in Gurugram and Manesar (Haryana) with immediate effect till further notice."

The company's research and development centre at Rohtak will also remain closed, it added.

The duration of this shutdown will depend upon government policy, MSI said.

The company's two plants in Haryana—Manesar and Gurgaon—churn out 15.5 lakh vehicles per annum.

HCIL said production operations at  manufacturing plants in Greater Noida (Uttar Pradesh) and Tapukara (Rajasthan) will suspended from 23-31 March.

The company said its intention is to restart production on 1 April, however, this will be dependent upon advice from the government, health authorities, and market and supply conditions.

M&M said it has suspended manufacturing operations at its Nagpur plant with immediate effect and will also halt production at Chakan (Pune) and Kandivali (Mumbai) from Monday.

None of the company plants is working on Sunday also, M&M added.

"We are carefully monitoring the rapidly evolving COVID-19 pandemic and will continue to take swift and appropriate action on other plants in Maharashtra and across the nation," the company said.

Meanwhile, all company offices across the country have been ordered to work from home, it added.

Similarly, automaker Fiat Chrysler Automobiles (FCA) together with Fiat India Automobiles Private Limited (FIAPL), FCA's joint venture manufacturing facility in Ranjangaon, said the temporary suspension is in response to the increasing prevalence of positive COVID-19 cases in Maharashtra and particularly in Pune.

"There will be no retrenchment of any plant employees as a result of the plant closure and all will continue to receive their salaries during this closure period", the company said.

MG Motor India said production at its Halol (Gujarat) plant is closed till 25 March.

Market leader Hero MotoCorp said it has suspended production until 31 March.

"With the safety and well-being of its employees as top priority in view of the escalating COVID-19 situation, the company has decided to halt operations at all its global manufacturing facilities—including in India, Colombia and Bangladesh—and the Global Parts Centre (GPC) at Neemrana with immediate effect until 31 March, 2020," Hero MotoCorp said.

Employees at all the other functions and locations, including the Centre of Innovation and Technology (CIT) at Jaipur, will continue to work from home, except for those whose physical presence is necessary to run the day-to-day essential services, it added.

Similarly, Honda Motorcycle and Scooter India (HMSI) said it has suspended operations across its four manufacturing plants in the country with immediate effect.

"The well-being of employees and all stakeholders being the top priority, the company has temporarily announced shutdown of operations across all its four manufacturing plants with immediate effect till further notice," HMSI

Story Input :Firstpost

Tags : #Maruti #Honda #Mahinda #Fiat #Heromotocorp #Hmsi #MGmotor

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Healthcare Trends in 2026: What India's Doctors, Hospitals, and Patients Need to KnowJuly 18, 2026
Monsoon Health Problems in India: Understanding the Risks, Symptoms, and PreventionJuly 18, 2026
Fortis Escorts Faridabad Launches Faridabad’s First Comprehensive Lung Failure Clinic for Advanced Respiratory and Transplant CareJuly 17, 2026
What Seemed Like Persistent Gas Turned Out To Be A 30-cm Rare Cancer Occupying Most Of Her AbdomenJuly 17, 2026
Kidney Stone Prevention Initiative Unites More Than 8,200 Doctors Across India, Earns Asia Book of Records RecognitionJuly 17, 2026
Moscow radiologists introduce AI tool for hip dysplasia diagnosisJuly 17, 2026
Sharrp Ventures leads 100 CR investment in Naturis Cosmetics’ first institutional funding roundJuly 17, 2026
Eugenix Challenges Hair Loss Stigma With Nationwide 'I Chose Transformation' Campaign Featuring Boney KapoorJuly 17, 2026
How Artificial Intelligence is Reshaping Preventive Healthcare Through Earlier Detection and Smarter Clinical InsightsJuly 17, 2026
Five Common Myths About Children's Urinary Problems That Parents Should Stop BelievingJuly 17, 2026
Robotics in Surgery: How Robot-Assisted Procedures Are Transforming Healthcare in IndiaJuly 17, 2026
Wearable Health Devices: How Smart Technology Is Changing Healthcare in IndiaJuly 17, 2026
Sankara Eye Hospitals Successfully Hosts 20th Annual VISION 2020 India Conference, Celebrating 50 Years of the Sankara MovementJuly 16, 2026
Manipal Hospital Bhubaneswar Successfully Treats Rare Brain Injury Caused by Post-Traumatic Workplace AccidentJuly 16, 2026
Immuneel Therapeutics and Tata Memorial Centre Sign Strategic MoU to Advance Cell and Gene Therapy Research in India July 16, 2026
Breast Cancer Early Warning Signs: What Every Woman in India Needs to KnowJuly 16, 2026
HbA1c Test Explained: What It Measures, Normal Range, and Why It Matters for IndiansJuly 16, 2026
Not Just Weight Loss: How Bariatric Surgery Improves Diabetes, PCOS, and Thyroid-Related Health ChallengesJuly 15, 2026
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety DisordersJuly 15, 2026
Dr Agarwals Institute of Optometry and SASTRA University Jointly Launch Optometry ProgrammeJuly 15, 2026